answer text |
<p>The Global Tuberculosis Report 2019 provides important evidence on the challenge
in tackling tuberculosis as an issue of global public health importance. We remain
committed to the global effort and the World Health Organisation End Tuberculosis
Strategy. We are proud to be at the forefront of work to prevent, detect and treat
tuberculosis, including funding research to develop new treatments to tackle drug
resistant tuberculosis. Our commitment to provide £1.4 billion to the latest replenishment
of the Global Fund will help provide tuberculosis treatment and care for over 2 million
people.</p><p> </p><p>A new tuberculosis vaccine could potentially have a significant
effect on reducing tuberculosis deaths, and there is cautious optimism about the results
for one potential vaccine, although there is still a very high degree of uncertainty
for this high-risk research. DFID carefully considers robust data on specific vaccines
before taking a view on its role in tackling a disease, including its relative impact
alongside other established interventions.</p>
|
|